Sheila Breslin

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Robert S. Negrin, Karl G. Blume, Sheila Breslin et al. · Blood · 2003 · 201 citations · Full text

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

Bradley C. Ekstrand, Jennifer B. Lucas, Steven M. Horwitz et al. · Blood · 2003 · 192 citations · Full text

Health-Related Quality of Life Results in Pathologic Stage C Prostate Cancer From a Southwest Oncology Group Trial Comparing Radical Prostatectomy Alone With Radical Prostatectomy Plus Radiation Therapy

Carol M. Moinpour, Katherine Hayden, Joseph M. Unger et al. · Journal of Clinical Oncology · 2007 · 145 citations · Full text

Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

Sandra J. Horning, Richard T. Hoppe, Sheila Breslin et al. · Journal of Clinical Oncology · 2002 · 115 citations

Secondary Leukemia, Cancer Management, Pathology +16

High failure rate associated with long‐term follow‐up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer

Michael L. Cher, Katsuto Shinohara, Sheila Breslin et al. · British Journal of Urology · 1995 · 49 citations